What does Illumina Ventures invest in?
Illumina Ventures invests most often at Series A and Venture (61% of the rounds on record), in sectors such as Spectrometry, Celle Therapy and Medical Device.

United States · Investor
Last cheque observed Sep 2026; 48 cheques on record.
Deploying nowVC firm
Follow Illumina Ventures and see its new cheques in your feed.Start following
11 cheques in the last 12 months
Mostly Series A and Venture: 61% of its rounds
Sole investor in 4 rounds, median $10M
Illumina Ventures is the leader in genomics and precision health investing.From their own website
Every round we can evidence, newest first48 appearances
9 rounds
12 rounds
5 rounds
4 rounds
5 rounds
2 rounds
2 rounds
5 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration2 named
We also hold 16 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From the firm's own filings with the SEC, which it must file accurately by law
From their own portfolio page (on their website)
CompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompanyCompany
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
The investors most often in the same rounds as Illumina Ventures. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Illumina Ventures put money into.
Illumina Ventures invests most often at Series A and Venture (61% of the rounds on record), in sectors such as Spectrometry, Celle Therapy and Medical Device.
48 investments on record, 11 of them in the last 12 months, and it led 1. The most recent was in Sept 2026.
Its most recent investments on record: CubaseBio (Grant, Sept 2026), Robigo (Series A, Sept 2026) and Integrated Biosciences (Venture, Aug 2026).
The median round it joins is $17M. It says it writes cheques of $500K to $10M.
Sometimes: it led 1 of its 48 investments on record (2%).
Most of the companies it backs are in the United States (78%), the United Kingdom (11%) and Sweden (5%).
Yes: it is actively investing, with 11 investments in the last 12 months.
Most often ARCH Venture Partners (7 rounds together), Alexandria Real Estate Equities (3 rounds together) and Alumni Ventures (3 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it